domingo, 16 de octubre de 2016

A pilot randomised controlled trial of the feasibility, acceptability and impact of giving information on personalised genomic risk of melanoma to ... - PubMed - NCBI

A pilot randomised controlled trial of the feasibility, acceptability and impact of giving information on personalised genomic risk of melanoma to ... - PubMed - NCBI



 2016 Oct 4. pii: cebp.0395.2016. [Epub ahead of print]

A pilot randomised controlled trial of the feasibility, acceptability and impact of giving information on personalised genomic risk of melanoma to the public.

Abstract

BACKGROUND:

Communication of personalised melanoma genomic risk information may improve melanoma prevention behaviours.

METHODS:

We evaluated the feasibility and acceptability of communicating personalised genomic risk of melanoma to the public, and its preliminary impact on behaviours and psychosocial outcomes. 118 people aged 22-69 years provided a saliva sample and were randomised to the control (non-personalised educational materials), or intervention (personalised booklet presenting melanoma genomic risk as absolute and relative risks and a risk category based on variants in 21 genes, telephone-based genetic counselling, and non-personalised educational materials). Intention-to-treat analyses overall and by risk category were conducted using ANCOVA adjusted for baseline values.

RESULTS:

Consent to participate was 41%, 99% were successfully genotyped, 92% completed 3-month follow-up. Intervention participants reported high satisfaction with the personalised booklet (mean=8.6, SD=1.6; on a 0-10 scale) and genetic counselling (mean=8.1, SD=2.2). No significant behavioural effects at 3-months follow-up were identified between intervention and control groups overall: objectively-measured standard erythemal doses per day (-16%, 95% confidence interval (CI): -43%, 24%), sun protection index (0.05, 95% CI: -0.07, 0.18). There was increased confidence identifying melanoma at 3-months (0.40, 95% CI: 0.10, 0.69). Stratified by risk category, effect sizes for intentional tanning and some individual sun protection items appeared stronger for the average-risk group. There were no appreciable group differences in skin cancer related worry or psychological distress.

CONCLUSION:

Our results demonstrate feasibility and acceptability of providing personalised genomic risk of melanoma to the public.

IMPACT:

Genomic risk information has potential as a melanoma prevention strategy.

PMID:
 
27702805
 
DOI:
 
10.1158/1055-9965.EPI-16-0395

[PubMed - as supplied by publisher]

No hay comentarios:

Publicar un comentario